Lilly

Lilly’s Trulicity scores CV reduction indication in the US

According to Lilly, the approval of Trulicity in both primary and secondary prevention populations is the first for any type 2 diabetes medicine. ... and without established cardiovascular disease," said Sherry Martin, vice president, medical affairs,

Lundbeck gets US approval for migraine drug at heart of Alder takeover

It’s also the first and only intravenously-administered CGRP antibody, as the current three drugs – Amgen/Novartis’ Aimovig (erenumab), Teva’s Ajovy (fremanezumab) and Eli Lilly’s Emgality (galcanezumab) – are ... Teva meanwhile said Ajovy

Incyte’s JAK inhibitor cream clears second eczema trial

The latter group includes Pfizer’s Xeljanz, (tofacitinib), Eli Lilly’s Olumiant (baricitinib) and AbbVie’s Rinvoq (upadacitinib), which have been approved for rheumatoid arthritis but are also in testing for

Double blow to amyloid drug hopes as Roche, Lilly trial fails

The two investigational candidates were unable to show benefit. A clinical trial of Roche and Eli Lilly anti-amyloid drugs in inherited forms of Alzheimer’s disease has ended in failure, ... Lilly’s solanezumab – which failed to move the needle in

New drugs drive Novo Nordisk despite insulin price pressures

Along with other insulin manufacturers, including Sanofi and Eli Lilly, Novo has  launched cut-price versions of its insulin products, as criticism over its prices continue to amplify.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]